Drug Candidate Selection
Drug candidate selection is the culminating decision point of the medicinal chemistry discovery process, at which a single compound, or occasionally a small...
Drug candidate selection is the culminating decision point of the medicinal chemistry discovery process, at which a single compound, or occasionally a small backup set, is formally nominated to proceed into the full preclinical development pathway described in the introductory phase of this text. Candidate selection integrates every data stream generated throughout the discovery programme — target potency and selectivity, comprehensive SAR understanding, physicochemical and ADMET properties, preliminary in-vivo efficacy and safety signals, synthetic route feasibility and scalability, and patentability position — into a single, multi-criteria decision, typically made by a cross-functional project team rather than by the medicinal chemistry function in isolation, reflecting the reality that a successful drug candidate must simultaneously satisfy scientific, manufacturing, regulatory, and commercial criteria rather than excelling in any single dimension alone.
Advanced Concepts: Multi-Target and AI-Guided Lead Optimization
Multi-target drug design, introduced in Phase 1, presents distinctive lead optimization challenges relative to single-target optimization, requiring simultaneous SAR tracking against two or more distinct binding sites and careful navigation of trade-offs where a structural modification favourable at one target may be neutral or unfavourable at the other. Artificial intelligence and machine-learning-guided lead optimization increasingly augments traditional SAR analysis by predicting the biological and physicochemical consequences of proposed structural modifications computationally, ahead of synthesis, using models trained on the accumulated SAR data from the current programme together with broader historical medicinal chemistry datasets, allowing a research team to prioritise the most information-rich next analogues to synthesise rather than exploring the available chemical space exhaustively.